Microvesicular caspase-1 mediates lymphocyte apoptosis in sepsis

Area of Science:

• Immunology
• Cell Biology
• Critical Care Medicine

Background:

• Sepsis involves immune dysregulation, with lymphocyte apoptosis linked to poor patient outcomes.
• The inflammasome, including caspase-1, plays a critical role in the innate immune response and sepsis-induced apoptosis.
• Previous research indicated that endotoxin-stimulated monocytes release microvesicles (MVs) containing caspase-1, capable of inducing apoptosis.

Purpose of the Study:

• To investigate the presence of caspase-1-containing MVs in the blood of human sepsis patients.
• To determine if these MVs contribute to lymphocyte apoptosis during sepsis.

Main Methods:

• A single-center cohort study involving 50 critically ill patients, categorized as septic or controls.
• Isolation and analysis of circulatory MVs for caspase-1 presence and apoptotic potential.
• Repeated measurements of caspase-1 activity on ICU day 3 for patients remaining in the ICU for 48 hours.

Main Results:

• Septic patients showed significantly higher microvesicular caspase-1 activity on ICU days 1 and 3 compared to controls.
• MVs from septic patients induced significantly more lymphocyte apoptosis than MVs from control patients.
• Apoptotic effects were dependent on active caspase-1 and intact microvesicles.

Conclusions:

• Microvesicular caspase-1 is a significant factor in the host response to sepsis, partly through inducing lymphocyte apoptosis.
• The pro-apoptotic function of MVs in sepsis requires active caspase-1 and intact microvesicle structure.